Yesterday, Sept. 3, 2015, 102 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $57.69 to $16,858,584.42.

Highlighted Stocks Traded by Insiders:

Inogen (INGN) - FREE Research Report

Bauerlein Alison, who is EVP, Finance & CFO at Inogen, sold 6,500 shares at $48.21 on Sept. 3, 2015. Following this transaction, the EVP, Finance & CFO owned 49,075 shares meaning that the stake was reduced by 11.7% with the 6,500-share transaction.

The shares most recently traded at $51.45, up $3.24, or 6.3% since the insider transaction. Historical insider transactions for Inogen go as follows:

  • 4-Week # shares sold: 13,333
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 13,333
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 13,333

The average volume for Inogen has been 266,700 shares per day over the past 30 days. Inogen has a market cap of $981.5 million and is part of the health care sector and health services industry. Shares are up 65.73% year-to-date as of the close of trading on Thursday.

Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company has a P/E ratio of 118.0. Currently, there are 5 analysts who rate Inogen a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on INGN - FREE

TheStreet Quant Ratings

rates Inogen as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in net income. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. Get the full

Inogen Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Watts Water Technologies (WTS) - FREE Research Report

Melhem Elie, who is President, Asia at Watts Water Technologies, sold 1,212 shares at $53.73 on Sept. 3, 2015. Following this transaction, the President, Asia owned 24,935 shares meaning that the stake was reduced by 4.64% with the 1,212-share transaction.

The shares most recently traded at $52.94, down $0.79, or 1.5% since the insider transaction. Historical insider transactions for Watts Water Technologies go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 6,670
  • 24-Week # shares sold: 7,670

The average volume for Watts Water Technologies has been 185,300 shares per day over the past 30 days. Watts Water Technologies has a market cap of $1.5 billion and is part of the industrial goods sector and industrial industry. Shares are down 15.02% year-to-date as of the close of trading on Thursday.

Watts Water Technologies, Inc. designs, manufactures, and sells water safety and flow control products in the Americas and Europe, Middle East and Africa, and Asia-Pacific. The stock currently has a dividend yield of 1.28%. The company has a P/E ratio of 41.0. Currently, there are 6 analysts who rate Watts Water Technologies a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WTS - FREE

TheStreet Quant Ratings

rates Watts Water Technologies as a

buy

. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

Watts Water Technologies Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Realpage (RP) - FREE Research Report

Seren Capital, Ltd., who is 10% Owner at Realpage, sold 390 shares at $18.05 on Sept. 3, 2015. Following this transaction, the 10% Owner owned 20.0 million shares meaning that the stake was reduced by 0% with the 390-share transaction.

The shares most recently traded at $17.88, down $0.17, or 0.95% since the insider transaction. Historical insider transactions for Realpage go as follows:

  • 4-Week # shares bought: 50,000
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 50,000
  • 12-Week # shares sold: 10,000
  • 24-Week # shares bought: 50,000
  • 24-Week # shares sold: 78,978

The average volume for Realpage has been 230,500 shares per day over the past 30 days. Realpage has a market cap of $1.4 billion and is part of the technology sector and computer software & services industry. Shares are down 18.94% year-to-date as of the close of trading on Thursday.

RealPage, Inc. provides demand software and software-enabled services for the rental housing and vacation rental industries in the United States. Currently, there are 2 analysts who rate Realpage a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RP - FREE

TheStreet Quant Ratings

rates Realpage as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and expanding profit margins. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full

Realpage Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.